Emotional perspective from the use of technology

Authors

  • Adriana Álvarez Italian Hospital of Buenos Aires, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.589

Keywords:

diabetes mellitus, tecnology

Abstract

Diabetes technology generally yields favourable results in terms of self-reported outcomes such as reduced diabetes distress, improved treatment satisfaction or reduced depression. This holds true for CSII and CGM, as well as for automated insulin delivery systems, albeit evidence for the latter is still limited.

Irrespective of the type of thecnology, a most intriguing and clinically relevant finding pertains to interindividual variability in diabetes thecnology uptake.Not all individuals use CSII or CGM consequentially (in terms of time the devices are used) and, therefore, cannot benefit from CSII or CGM to the full extent. It remains to be fully clarified as to why some individuals do not engage with diabetes technologies or even discontinue their use altogether, Furthermore, healthcare professionals need to be able to provide education about technologies; however, not all are able to discuss CGM/pump/automated insulin delivery system data.

Author Biography

Adriana Álvarez, Italian Hospital of Buenos Aires, Autonomous City of Buenos Aires, Argentina

Physician specialist in Endocrinology; Staff Physician of the Endocrinology, Metabolism and Nuclear Medicine Service

References

I. Kubiak T, Priesterroth L, Barnard-Kelly KD. Psychosocial aspects of diabetes technology. Diabet Med 2020;37(3):448:545. doi: 10.1111/dme.14234.

Downloads

Published

2022-09-01

How to Cite

Álvarez, A. (2022). Emotional perspective from the use of technology. Journal of the Argentine Society of Diabetes, 56(3Sup), 90–90. https://doi.org/10.47196/diab.v56i3Sup.589

Issue

Vol. 56 No. 3Sup (2022): September/December 2022

Section

Technology applied to psychosocial aspects in type 1 diabetes mellitus

License

Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.